Introduction
============

Chronic open-angle glaucoma is a multifactorial disorder of the optic nerve, and its main risk factor is elevated intraocular pressure (IOP). Current treatment for glaucoma focuses solely on reducing IOP, although some patients continue to progress even when IOP reaches the predetermined target level. Further, some individuals develop the disease at low IOP values, which is known as normal tension glaucoma. Therefore, it is reasonable to assume that risk factors other than IOP itself may contribute to the etiopathogenesis of glaucoma. Among these, vascular disorders, including atherosclerosis, migraine, Raynaud's phenomenon, and other vasospastic conditions, have been identified as potential risk factors for glaucoma.[@b1-opth-7-1615]--[@b8-opth-7-1615]

The influence of blood pressure (BP) as an independent risk factor for glaucoma remains controversial. Although some studies have shown a significant positive correlation between systemic hypertension and glaucoma,[@b9-opth-7-1615],[@b10-opth-7-1615] Leske et al found a negative correlation between these two variables.[@b11-opth-7-1615] However, because BP and IOP tend to show circadian variation, their fluctuations may also be related to progression of glaucoma.[@b12-opth-7-1615]

A number of methods can be used to investigate the vascular factors related to glaucoma. One is to measure ocular perfusion pressure, reduction of which is suspected to be an important risk factor for glaucoma.[@b13-opth-7-1615]--[@b15-opth-7-1615] Another way to assess the vascular component in glaucoma is to measure the ocular pulse amplitude by dynamic contour tonometry (DCT).[@b16-opth-7-1615] The IOP varies according to the cardiac cycle, and this variation can be detected by rhythmic oscillation of the semicircles in Goldmann applanation tonometry (GAT). DCT measures the amplitude of the IOP variation between systole and diastole.[@b17-opth-7-1615]

The purpose of this study was to evaluate the correlation between ocular perfusion pressure and ocular pulse amplitude in glaucoma, ocular hypertension, and normal eyes.

Materials and methods
=====================

Ninety eyes from 90 patients were enrolled and divided into three groups. The glaucoma group included individuals recently diagnosed with the disease and no previous treatment. The ocular hypertension and normal groups had no identifiable functional and/or structural glaucoma damage indicated by IOP. The study was approved by the ethics committee of the Federal University of Minas Gerais, Brazil. Written informed consent was obtained from each participant. The research followed the tenets of the Declaration of Helsinki. Evaluation of the 90 patients was conducted by the same physician (BPF) during the period from September 2008 to May 2010.

The inclusion criteria were age older than 40 years, an open angle on gonioscopy, and best corrected visual acuity of 20/40 or better. For a patient to be entered into the glaucoma group, coexistence of optic disc signs of glaucoma as well as damage in the visual field suggestive of glaucoma was necessary.

Examination of optic nerve
--------------------------

Evaluation of the optic disc and papillary retinal nerve fiber layer was done at slit-lamp examination using a 78 diopter lens. Identification of glaucomatous optic neuropathy was based on at least two of the following criteria: cup/disc ratio \>0.6; localized rim loss in the superior or inferior quadrant; disc hemorrhage; and cup/disc asymmetry \>0.2.[@b11-opth-7-1615]

Examination of visual field
---------------------------

The visual field was measured using a Humphrey field analyzer (Carl Zeiss Meditec Inc, Dublin, CA, USA) program 24--2 and the standard SITA strategy. Glaucoma damage was defined as the presence of at least two of the following criteria: a cluster of three or more nonedge points, all of which were depressed on the pattern deviation plot at a *P* \< 0.05 level and one of which was depressed at *P* \< 0.01 of normal fields; a glaucoma hemifield test outside normal limits; and pattern standard deviation at *P* \< 0.05 of normal fields. The visual field examination was repeated for each eye to check reproducibility of the findings, and if necessary, a third examination was performed within a week. In the event of incongruous data being obtained at the three examinations, the patient was excluded from the study. The criteria for reliability were: false positive \<33%, false negative \<33%, and fixation loss \<20%.[@b18-opth-7-1615]

Goldmann applanation tonometry
------------------------------

IOP was measured using a Goldmann applanation tonometer between 8 am and 9 am, always repeating the measurement within five minutes. In the event of the difference between the two values being less than 2 mmHg, the lower value was used. If the difference was greater than 2 mmHg, a third measurement was taken, and the lower value was to be considered, but still respecting the 2 mmHg difference between measurements. In the event of a difference greater than 2 mmHg between the three values, the patient was excluded from the study.

The individuals with ocular hypertension and the controls had none of the previously mentioned signs of glaucoma during examination of their optic nerve and/or visual field. Allocation to either of these two groups was based on the IOP value. The ocular hypertension group contained individuals with IOP ≥21 mmHg and the control group contained those with IOP \<21 mmHg.

Dynamic contour tonometry
-------------------------

DCT readings were recorded using a Pascal tonometer (Swiss Microtechnology AG, Port, Switzerland) between 8 am and 9 am. The quality of DCT measurement ranges from 1 to 5 (1 being optimal and 5 being least optimal), and only readings with quality levels of 1 and 2 were included in this study. Ocular pulse amplitude given by DCT represents the difference between systolic and diastolic IOP.

Blood pressure
--------------

BP was measured using a brachial sphygmomanometer (DS66, Welch Allyn, Skaneateles, NY, USA) and a Littmann Classic II stethoscope (3M, St Paul, MN, USA) on the upper right arm after the subject had been seated for at least 5 minutes. Caffeine, exercise, and smoking were not allowed for at least 30 minutes prior to examination. Two measurements were taken at 5 minute intervals and the average value recorded.[@b19-opth-7-1615]

Ocular perfusion pressure
-------------------------

By definition, perfusion pressure is calculated as follows: PP = MAP − VP, where PP is perfusion pressure, MAP is mean arterial pressure, and VP is venous pressure. The MAP formula is: MAP = DBP + \[1/3 × (SBP − DBP)\], where PP is perfusion pressure, DBP is diastolic blood pressure, and SBP is systolic blood pressure. To obtain the ocular perfusion pressure, one can use the perfusion pressure formula, substituting venous pressure for IOP. Because the blood pressure in the ophthalmic artery is 2/3 of brachial BP, the final ocular perfusion pressure formula is as follows: ocular perfusion pressure = 2/3 MAP − IOP.

Gonioscopy and central corneal thickness
----------------------------------------

Gonioscopy was performed using a Sussman lens (Ocular Inc, Dallas, TX, USA) and ultrasound pachymetry was performed using the DGH 555 device (DGH Technology Inc, Exton, PA, USA). Individuals with a previous history of glaucoma medication, ocular surgery, or laser procedures in the eye, a corneal disorder that could interfere with optimal GAT or DCT, spherical equivalent \>±4.0 D, advanced cataract, or evidence of ocular infection were excluded from the study.

Statistical analysis
--------------------

In the glaucoma group, the eye selected for statistical analysis was the one with lower cup/disc ratio, respecting the minimum 0.6 value. In the event of equal ratios in both eyes, the lower IOP eye was selected. If IOP was also the same, the right eye was used in the study. In the ocular hypertension group, the eye with the lower IOP was selected respecting the 21 mmHg value. In the event that the patient had the same IOP in both eyes, the right eye was selected. The right eye was always chosen in the normal group.

Univariate analysis was performed comparing ocular pulse amplitude and ocular perfusion pressure between the three groups using the *F*-test (analysis of variance) in the event of variables with a normal distribution. The Kruskal--Wallis test was used in the event of a non-normal distribution. Verification of distribution was performed using the Shapiro--Wilk test. When the *P*-value was significantly different between the three groups, a post hoc two on two comparisons was performed using either the Tukey range test (parametric) or the Mann--Whitney test with Bonferroni adjustment (nonparametric); the *P*-value for these two tests was 0.017 because there were three groups involved (0.05/3).

To evaluate the relationship between ocular pulse amplitude (OPA) and ocular perfusion pressure, the Pearson correlation coefficient was calculated in the event of two variables having a normal distribution or Spearman rank's correlation coefficient if one of the variables had a nonnormal distribution. Statistical analysis was performed using R software version 2.14.1.

Results
=======

The mean patient age was 57.2 ± 9.9 years in the glaucoma group, 49.9 ± 8.7 years in the ocular hypertension group, and 52.3 ± 7.2 years in the control group. There was a statistical difference between these mean ages when the three groups were compared (*P* = 0.009, Kruskal--Wallis test). A paired comparison between the groups showed a significant difference only when patients with glaucoma and those with ocular hypertension were compared (*P* = 0.005, Mann--Whitney test/Bonferroni adjustment). Fifty-one subjects (56.7%) were white, 30 (33.3%) were "pardos" (ie, of mixed ethnicity), and nine (10%) were of African descent. Forty-eight (53.3%) men and 42 (46.7%) women were included in the study. There were 18 (60%) men in the glaucoma group, 14 (46.7%) in the ocular hypertension group, and 16 (53.3%) in the control group.

IOP was measured by GAT or DCT. Mean (standard deviation), median, and range values are shown in [Table 1](#t1-opth-7-1615){ref-type="table"}. The mean difference between the measurements obtained with the two techniques was 1.7 mmHg. Despite this difference, a high positive correlation was found when studying these two methods (*r* = 0.832 and *P* \< 0.01; [Figure 1](#f1-opth-7-1615){ref-type="fig"}).

We also tested the correlation between each method of measuring IOP and central corneal thickness, and found a slight positive correlation between GAT and central corneal thickness (*r* = 0.230 and *P* = 0.029), but no correlation between DCT and central corneal thickness (*r* = −0.005 and *P* = 0.965).

Mean (standard deviation) values for ocular pulse amplitude and perfusion pressure in the three groups are shown in [Table 2](#t2-opth-7-1615){ref-type="table"}. Ocular pulse amplitude ranged from 1.6 mmHg to 6.4 mmHg (glaucoma group), 0.9 mmHg to 6.0 mmHg (ocular hypertension group), and 0.9 to 4.9 mmHg (in the group, [Figure 2](#f2-opth-7-1615){ref-type="fig"}). The difference between the three groups was statistically significant (*P* = 0.002, *F* test). A Tukey range test was then used, and showed a significant difference between the glaucoma and control groups (*P* = 0.014) and between the ocular hypertension and control groups (*P* = 0.003). There was no statistically significant difference between the glaucoma and ocular hypertension groups (*P* = 0.887).

Ocular perfusion pressure ranged from 32.2 mmHg to 63.8 mmHg (glaucoma group), 27.1 mmHg to 54.6 mmHg (ocular hypertension group), and 37.3 mmHg to 63.3 mmHg (normal group, [Figure 3](#f3-opth-7-1615){ref-type="fig"}). The Mann--Whitney test with Bonferroni adjustment was used to compare pairs of groups, and showed a significant difference between the glaucoma and ocular hypertension groups (*P* = 0.010) and between the ocular hypertension and control groups (*P* \< 0.001). There was no statistically significant difference between the glaucoma and control groups (*P* = 0.026).

Systolic blood pressure was 131.0 ± 16.7 mmHg in the glaucoma group, 125.0 ± 12.3 mmHg in the ocular hypertension group, and 121.5 ± 12.1 mmHg in the control group, and diastolic blood pressure was 82.2 ± 11.3 mmHg, 81.2 ± 6.9 mmHg, and 81.5 ± 9.0 mmHg, respectively.

[Table 3](#t3-opth-7-1615){ref-type="table"} shows the correlation between ocular pulse amplitude and ocular perfusion pressure for the three groups. A significant correlation was not observed (*P* \> 0.05) for these two variables between any of the three groups evaluated separately or when tested together.

Discussion
==========

Accurate IOP measurement is critical in the diagnosis and treatment of patients with glaucoma. GAT has been the gold standard for measurement of IOP for over 50 years, although questions regarding its validity have arisen since publication of the Ocular Hypertensive Treatment Study and European Glaucoma Progression Study, both of which identified a relationship between corneal central thickness and IOP.[@b20-opth-7-1615] Other studies have confirmed the influence of corneal properties and biomechanics on IOP measured by GAT.[@b21-opth-7-1615]--[@b24-opth-7-1615] DCT is an alternative way to measure IOP, and is based on a completely new physical principle that does not distort the corneal anatomy.[@b16-opth-7-1615] Therefore, DCT seems to be less affected by factors such as corneal thickness and hysteresis when compared with GAT.[@b25-opth-7-1615] In our study, the difference between mean measurements taken on DCT and GAT was 1.7 mmHg. A similar difference has been observed in other studies, ranging from 0.7 mmHg to 2.8 mmHg. A positive correlation between DCT and GAT is also reported in the literature, as well as in the present study.[@b26-opth-7-1615]--[@b33-opth-7-1615] Doyle and Lachkar[@b28-opth-7-1615] reported a study showing that individuals with normal or high central corneal thickness had similar IOP values on GAT and DCT, and that IOP values for a thin cornea tended to show a higher discrepancy between the two measurements, possibly due to underestimation of IOP by the Goldmann tonometer. DCT measurements tend to be less influenced by central corneal thickness than measurements obtained on GAT,[@b27-opth-7-1615],[@b28-opth-7-1615],[@b34-opth-7-1615],[@b35-opth-7-1615] especially in individuals with thin corneas.

Another advantage of DCT is that it measures IOP in a continuous manner, and so captures variation in IOP during the cardiac cycle.[@b16-opth-7-1615] The rhythmic oscillation of IOP is measured by DCT and presented as the ocular pulse amplitude. The role of ocular pulse amplitude in glaucoma is still unclear. Weizer et al published a study correlating ocular pulse amplitude with severity of glaucoma, and concluded that a high ocular pulse amplitude seems to be related to less severe glaucoma.[@b30-opth-7-1615] Schwenn et al showed that a low ocular pulse amplitude was more likely to be present in normal tension glaucoma than in primary open angle glaucoma, ocular hypertension, or normal eyes.[@b36-opth-7-1615] Kynigopoulos et al found a relationship between low ocular pulse amplitude and presence of functional and structural damage in primary open angle glaucoma.[@b37-opth-7-1615] In our study, the mean ocular pulse amplitude was significantly lower in the control group than in the glaucoma or ocular hypertension groups. A possible reason for this is the positive correlation between GAT and ocular pulse amplitude, as explained by Punjabi et al[@b38-opth-7-1615] and Kaufmann et al.[@b39-opth-7-1615] In our study, we did not use high IOP (\>21 mmHg) as an inclusion criterion for the glaucoma group. Therefore, the mean IOP in the ocular hypertensive group was higher than in the glaucoma patients.

According to the ocular perfusion pressure formula, one has low ocular perfusion pressure when blood pressure is relatively low and IOP is relatively high. A number of population-based epidemiologic studies have demonstrated a relationship between low ocular perfusion pressure and glaucoma.[@b11-opth-7-1615],[@b13-opth-7-1615],[@b40-opth-7-1615]--[@b42-opth-7-1615] There is no consensus on a reference value to differentiate between normal and altered ocular perfusion pressure. Leske et al found that ocular perfusion pressure \<42 mmHg was associated with a higher risk of developing glaucoma (relative risk 2.2).[@b11-opth-7-1615] In the present study, the normal group had a mean ocular perfusion pressure ranging from 43.2 mmHg to 57.2 mmHg, ie, above the cutoff value of 42 mmHg proposed on the basis of the results from the Barbados study.[@b11-opth-7-1615] In the ocular hypertension group, we found a low mean ocular perfusion pressure that could be explained by a high mean IOP and the fact that ocular perfusion pressure and IOP are inversely proportional. We assumed that ocular perfusion pressure was higher in our glaucoma group because we did not include only glaucoma patients with high IOP.

Assessment of ocular blood flow using ocular perfusion pressure and/or ocular pulse amplitude can be rather limited for two main reasons. First, fluctuation in measurements, especially at night, when blood pressure drops dramatically, can occur in patients defined as nonphysiologic dippers, leading to poor perfusion of the optic nerve.[@b43-opth-7-1615],[@b45-opth-7-1615] Also, both ocular perfusion pressure and ocular pulse amplitude are more related to IOP itself than any other factor that could directly influence ocular blood flow. The association between vascular risk factors, including ocular perfusion pressure and ocular pulse amplitude, in glaucoma has been the subject of several recent studies, all of which showed no significant correlation between these two vascular factors.[@b46-opth-7-1615],[@b47-opth-7-1615] Ocular perfusion pressure and ocular pulse amplitude may have independent roles in the three types of patients included in this study. Systemic vascular regulation as well as the impact of treatment on systemic disorders must also affect patients in an independent manner. There is still much to learn about the complex interaction between these factors.

Conclusion
==========

In conclusion, our results show no correlation between ocular perfusion pressure and ocular pulse amplitude in glaucoma, ocular hypertension, or normal eyes. We found a strong correlation between GAT and DCT. Corneal thickness was slightly related to GAT and not related to DCT.
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###### 

Intraocular pressure by Goldmann applanation tonometry and dynamic contour tonometry

  IOP                    n    Mean (SD)    Median   Range
  ---------------------- ---- ------------ -------- ------------
  DCT                    90   19.8 (5.0)   19.7     10.2--31.9
   Glaucoma              30   22.7 (4.3)   23.2     13.7--31.9
   Ocular hypertension   30   22.3 (2.8)   22.2     16.6--27.9
   Normal                30   14.3 (1.6)   14.3     10.2--17.5
  GAT                    90   18.1 (5.2)   20.0     10.0--30.0
   Glaucoma              30   19.0 (5.1)   20.5     10.0--30.0
   Ocular hypertension   30   22.4 (2.1)   22.0     21.0--27.0
   Normal                30   12.9 (2.2)   13.0     10.0--17.0

**Note:** All data are expressed in mmHg.

**Abbreviations:** DCT, dynamic contour tonometry; GAT, Goldmann applanation tonometry; IOP, intraocular pressure; SD, standard deviation.

###### 

Ocular pulse amplitude and ocular perfusion pressure in glaucoma, ocular hypertension, and normal eyes

  Group                 Ocular pulse amplitude   Ocular perfusion pressure                                        
  --------------------- ------------------------ --------------------------------------------------- ------------ -------------------------------------------------------
  Glaucoma              3.4 (1.2)                0.002[\*](#tfn3-opth-7-1615){ref-type="table-fn"}   46.3 (7.9)   \<0.001[\*\*](#tfn4-opth-7-1615){ref-type="table-fn"}
  Ocular hypertension   3.5 (1.2)                                                                    41.5 (5.2)   
  Normal                2.6 (0.9)                                                                    50.2 (7.0)   

**Notes:**

Statistically significant in *F*-test (analysis of variance);

statistically significant in Kruskal--Wallis test. All data are expressed in mmHg.

**Abbreviation:** SD, standard deviation.

###### 

Correlation between ocular perfusion pressure and ocular pulse amplitude

  Ocular perfusion pressure   Ocular pulse amplitude   
  --------------------------- ------------------------ -----------------------------------------------------
  Patient groups                                       
   Glaucoma                   −0.032                   0.865[\*](#tfn6-opth-7-1615){ref-type="table-fn"}
   Ocular hypertension        −0.156                   0.403[\*](#tfn6-opth-7-1615){ref-type="table-fn"}
   Normal                     −0.307                   0.082[\*\*](#tfn7-opth-7-1615){ref-type="table-fn"}

**Notes:**

Statistically significant Pearson correlation coefficient

statistically significant Spearman correlation coefficient.
